Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

Overexpression rates of HER2 in gastric cancer

Dr Florian Lordick - Klinikum Braunschweig and Hannover Medical School, Germany
Overexpression rates of HER2 in gastric cancer ( Dr Florian Lordick - Klinikum Braunschweig and Hannover Medical School, Germany )
30 Mar 2010

Role of the German Cancer Congress

Dr Johannes Bruns - General Secretary, German Cancer Society (DKG)
Role of the German Cancer Congress ( Dr Johannes Bruns - General Secretary, German Cancer Society (DKG) )
30 Mar 2010

The German Cancer Research Center

Professor Otmar Wiestler - University of Heidelberg, Germany
The German Cancer Research Center ( Professor Otmar Wiestler - University of Heidelberg, Germany )
30 Mar 2010

Development of a national cancer plan in Germany

Dr Werner Hohenberger - University of Erlangen, Germany
Development of a national cancer plan in Germany ( Dr Werner Hohenberger - University of Erlangen, Germany )
30 Mar 2010

Urology cancer care in Germany

Dr Manfred Wirth - Technical University Dresden, Germany
Urology cancer care in Germany ( Dr Manfred Wirth - Technical University Dresden, Germany )
30 Mar 2010

Preventative oncology in Germany

Professor Cornelia Ulrich - National Center of Tumour Diseases, Germany
Preventative oncology in Germany ( Professor Cornelia Ulrich - National Center of Tumour Diseases, Germany )
30 Mar 2010

Roundtable discussion on the latest advances in multiple myeloma therapy

Prof Gordon McVie, Prof Thierry Facon, Prof Meletios Dimopoulos, Prof Heinz Ludwig
Roundtable discussion on the latest advances in multiple myeloma therapy ( Prof Gordon McVie, Prof Thierry Facon, Prof Meletios Dimopoulos, Prof Heinz Ludwig )
2 Mar 2010

ASH 2009: Bortezomib, lenalidomide, liposomal doxorubicin and dexamethasone for multiple myeloma

Prof Andrzej Jakubowiak - University of Michigan Comprehensive Cancer Center, USA
ASH 2009: Bortezomib, lenalidomide, liposomal doxorubicin and dexamethasone for multiple myeloma ( Prof Andrzej Jakubowiak - University of Michigan Comprehensive Cancer Center, USA )
1 Mar 2010

ASH 2009: New treatments for multiple myeloma

Prof Antonio Palumbo - University of Torino, Italy
ASH 2009: New treatments for multiple myeloma ( Prof Antonio Palumbo - University of Torino, Italy )
1 Mar 2010

ASH 2009: Oral panobinostat and bortezomib for relapsed multiple myeloma

Prof Jesus Fernando San-Miguel - University Hospital of Salamanca, Spain
ASH 2009: Oral panobinostat and bortezomib for relapsed multiple myeloma ( Prof Jesus Fernando San-Miguel - University Hospital of Salamanca, Spain )
1 Mar 2010

ASH 2009: New regimens for elderly multiple myeloma patients

Dr Maria-Victoria Mateos - University Hospital of Salamanca, Spain
ASH 2009: New regimens for elderly multiple myeloma patients ( Dr Maria-Victoria Mateos - University Hospital of Salamanca, Spain )
1 Mar 2010

ASH 2009: Tackling polyneuropathy associated with bortezomib

Dr Pieter Sonneveld - University Hospital Rotterdam, The Netherlands
ASH 2009: Tackling polyneuropathy associated with bortezomib ( Dr Pieter Sonneveld - University Hospital Rotterdam, The Netherlands )
1 Mar 2010

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation